Novacyt (ALTERNEXT: ALNOV), an international specialist in cancer and infectious disease diagnostics, held Monday 22 February an Extraordinary General Meeting (“EGM”) related to the acquisition of Primerdesign Ltd (“Primerdesign”) and...

Novacyt (ALTERNEXT: ALNOV), an international specialist in cancer and infectious disease diagnostics, updates the market on its intended acquisition of Primerdesign Ltd (“Primerdesign”), a profitable and rapidly growing UK molecular...